62871-12-9

Basic information

• Product Name: 5-chloro-2-ethoxybenzoic acid
• Synonyms: 5-chloro-2-ethoxybenzoic acid;2-ethoxy-5-chloro-benzoic acid
• CAS NO: 62871-12-9
• Molecular Formula: C₉H₉ClO₃
• Molecular Weight: 200.61896
• Mol File: 62871-12-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 321.3±22.0 °C(Predicted)
• Appearance: /
• Density: 1.299±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 3.84±0.10(Predicted)
• CAS DataBase Reference: 5-chloro-2-ethoxybenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-chloro-2-ethoxybenzoic acid(62871-12-9)
• EPA Substance Registry System: 5-chloro-2-ethoxybenzoic acid(62871-12-9)

Safety Data

• Hazardous Substances Data: 62871-12-9(Hazardous Substances Data)

Usage

Uses

5-Chloro-2-ethoxybenzoic Acid can be used to prepare for herbicidal activity.

Upstream product

• 134-11-2 2-ethoxybenzoic acid 
• 73119-79-6 ethyl 5-chloro-2-ethoxybenzoic acid 
• 321-14-2 5-chloro-2-hydroxybenzoic acid 
• 15196-83-5 5-chlorosalicylic acid ethyl ester 

Downstream Products

• 60531-34-2 5-chloro-2-ethoxybenzoylchloride 
• 75230-20-5 N-(5-Chloro-2-ethoxy-benzoyl)-N'-cyclooctyl-guanidine; hydrochloride 
• 75230-37-4 methyl 5-chloro-2-ethoxybenzoate 

Relevant articles and documents

AMINO PYRAZOLONE DERIVATIVE HAVING CONDENSED RING STRUCTURE

PROBLEM TO BE SOLVED: To provide a compound that has excellent inhibitory action on ATPase activity of TIP48/TIP49 complex and is therefore useful for the treatment of tumor, or a pharmacologically acceptable salt thereof. SOLUTION: The present invention provides a compound having a structure represented by general formula (I), its pharmacologically acceptable salt, or a pharmaceutical composition comprising the compound (where R3, R4, R5, R6, R7, W, X, Y, and Z are as defined in the specifications). SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT

AMINOPYRAZOLONE DERIVATIVE

The present invention is intended to provide a compound or a pharmacologically acceptable salt thereof which has an excellent inhibitory action on the ATPase activity of a TIP48/TIP49 complex and as such, is useful for the treatment of tumors. [Solution] The present invention provides a compound having a structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, and a pharmaceutical composition comprising the compound. In the formula, R1, R2, R3, R4, R5, R6, R7, and W are as defined in the present specification.

NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS AND USES THEREOF

The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a and (Rx)n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.